Iovance faces major setbacks with AMTAGVI's weak launch, cash burn, and scalability issues despite scientific progress. Find ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.

Understanding how drug delivery systems distribute in vivo remains a major challenge in developing nanomedicines. Especially ...

A change to Medicare payments, set to take effect in 2028, could force infusion centers to close, leaving patients in the lurch.

Experts from CO Architects, SOM, UW Health, City of Hope, and E4H discuss design trends shaping cancer care facility projects ...

Northwell Health unveiled a $1.1 million, 2,400-square-foot expansion of outpatient infusion at the R.J. Zuckerberg Cancer ...

As radiopharmaceutical therapies gain momentum, new challenges are emerging in how they’re administered—especially around ...

Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three ...

The new Helmsley Cancer Center is set to transform cancer care in rural Montana by offering comprehensive radiation oncology services alongside existing medical and surgical oncology.

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...